[go: up one dir, main page]

KR100257550B1 - 신규 피리딘 유도체 및 이를 유효성분으로 하는 의약 - Google Patents

신규 피리딘 유도체 및 이를 유효성분으로 하는 의약 Download PDF

Info

Publication number
KR100257550B1
KR100257550B1 KR1019970707935A KR19970707935A KR100257550B1 KR 100257550 B1 KR100257550 B1 KR 100257550B1 KR 1019970707935 A KR1019970707935 A KR 1019970707935A KR 19970707935 A KR19970707935 A KR 19970707935A KR 100257550 B1 KR100257550 B1 KR 100257550B1
Authority
KR
South Korea
Prior art keywords
group
formula
propenyl
oxo
melting point
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019970707935A
Other languages
English (en)
Korean (ko)
Other versions
KR19990008408A (ko
Inventor
히로시 하세가와
타다시 미카미
고이치 다치바나
가즈오 야마자키
노리유키 가와모토
노리아키 시오이리
고지 구사노
스스무 사토
히데아키 마츠다
도시오 요코야마
Original Assignee
타이도 나오카타
에스에스 세야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 타이도 나오카타, 에스에스 세야쿠 가부시키가이샤 filed Critical 타이도 나오카타
Publication of KR19990008408A publication Critical patent/KR19990008408A/ko
Application granted granted Critical
Publication of KR100257550B1 publication Critical patent/KR100257550B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
KR1019970707935A 1996-03-15 1997-03-07 신규 피리딘 유도체 및 이를 유효성분으로 하는 의약 Expired - Fee Related KR100257550B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5890696 1996-03-15
JP58906/1996 1996-03-15

Publications (2)

Publication Number Publication Date
KR19990008408A KR19990008408A (ko) 1999-01-25
KR100257550B1 true KR100257550B1 (ko) 2000-07-01

Family

ID=13097864

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970707935A Expired - Fee Related KR100257550B1 (ko) 1996-03-15 1997-03-07 신규 피리딘 유도체 및 이를 유효성분으로 하는 의약

Country Status (6)

Country Link
US (1) US6046218A (fr)
EP (1) EP0838457A4 (fr)
KR (1) KR100257550B1 (fr)
CN (1) CN1182419A (fr)
CA (1) CA2220231A1 (fr)
WO (1) WO1997033870A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100517452B1 (ko) * 1996-09-25 2007-03-15 히사미쓰 메디카루 가부시키가이샤 치환 비닐피리딘 유도체 및 이를 함유하는 의약
WO2007032591A1 (fr) * 2005-09-13 2007-03-22 Industry-Academic Cooperation Foundation, Yeungnam University Composition comprenant 1-furan-2-yl-3-pyridine-2-yl-propenone presentant une activite anti-angiogenique et une activite inhibitrice du cancer
ES2526567T3 (es) * 2009-11-18 2015-01-13 Fab Pharma Sas Acrilamidas azaheterocíclicas y su uso como bactericidas

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8303097D0 (en) * 1983-02-04 1983-03-09 Fujisawa Pharmaceutical Co Heterocyclic derivatives
JPS6127168A (ja) * 1984-07-16 1986-02-06 Nippon Steel Corp Ｕｏ鋼管のタブ板切断方法
JPH0647570B2 (ja) * 1985-05-24 1994-06-22 久光製薬株式会社 カルボン酸アミド誘導体
JPH01290683A (ja) * 1988-05-18 1989-11-22 Banyu Pharmaceut Co Ltd 二環性複素環チオメチルセフェム誘導体
IE912064A1 (en) * 1990-06-18 1991-12-18 Merck & Co Inc Inhibitors of hiv reverse transcriptase
JPH04202127A (ja) * 1990-11-30 1992-07-22 Terumo Corp インターロイキン―１産生抑制剤
JPH04202126A (ja) * 1990-11-30 1992-07-22 Terumo Corp インターロイキン―１産生抑制剤
JP3145709B2 (ja) * 1991-05-09 2001-03-12 バーテックス ファーマシューティカルズ インコーポレイテッド 新規な免疫抑制化合物

Also Published As

Publication number Publication date
EP0838457A1 (fr) 1998-04-29
US6046218A (en) 2000-04-04
EP0838457A4 (fr) 1999-06-30
CN1182419A (zh) 1998-05-20
KR19990008408A (ko) 1999-01-25
WO1997033870A1 (fr) 1997-09-18
CA2220231A1 (fr) 1997-09-18

Similar Documents

Publication Publication Date Title
US6335341B1 (en) Pyridyl-and pyrimidyl-heterocyclic compounds inhibiting oxido squalene-cyclase
US4940705A (en) N-substituted derivatives of 1-desoxynojirimycin and 1-desoxymannonojirimycin and pharmaceutical use
US5654309A (en) Pyridopyrimidine derivatives, their production and use
US6335332B1 (en) Barbituric acid derivatives with antimetastatic and antitumor activity
US8536184B2 (en) Nitrogenous heterocyclic compounds and process for making nitrogenous heterocyclic compounds and intermediates thereof
HK32289A (en) 2-substituted 4-amino-6,7-dimethoxyquinolines
CS228506B2 (en) Method for the production of optical active ester of 1,4-dihydropyridincarboxyl acid
SK18499A3 (en) Substituted pyrimidine derivatives and their pharmaceutical use
EP1870405A1 (fr) (Aza)cyclohexanes carbonylées comme ligands du récepteur D3 de la dopamine
MXPA04011246A (es) Compuestos de amidas de acido 3-amino-tieno[2,3-b]piridin-2-carboxilico sustituido y procesos para preparar y sus usos.
JP2003522773A (ja) 血管形成および／またはｖｅｇｆ受容体チロシンキナーゼを阻害するピリジン誘導体
US4661485A (en) 2-pyrimidylaminoalkoxymethyl-6-methyl-3,5-bis (alkoxycarbony-1)-1,4-dihydropyridine antihypertensive agents
WO2007031829A2 (fr) Nouveaux pyrimidine carboxamides
US4567188A (en) Hypotensive 2-nitro-1,1-ethenediamines
EP0494850A2 (fr) Nouveaux composés antiviraux
EP0784055A1 (fr) Derive pyrimidinylpyrazole
EP1628968B1 (fr) Composes de 4-imidazoline-2-one
KR100257550B1 (ko) 신규 피리딘 유도체 및 이를 유효성분으로 하는 의약
US4390536A (en) Piperidine derivatives
US7329655B2 (en) Nitrogenous heterocyclic compounds
US20080319031A1 (en) Novel Tyrosine Derivatives
US7247645B2 (en) Dihydropyridine derivatives
US7101873B2 (en) Pyrimidinedione derivatives
EP1736472A1 (fr) Dérivé de 2-aminopyridine
JPH11180952A (ja) ２−オキシインドール誘導体

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20030303

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20030303

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000